A phase I study of R-(-)-gossypol (AT-101) in combination with cisplatin (P) and etoposide (E) in patients (pts) with advanced solid tumors and extensive-stage small cell lung cancer (ES-SCLC).
A. M. Traynor
No relevant relationships to disclose
J. Kolesar
No relevant relationships to disclose
R. M. Marnocha
No relevant relationships to disclose
J. C. Eikhoff
No relevant relationships to disclose
D. B. Alberti
No relevant relationships to disclose
N. Takebe
No relevant relationships to disclose
G. Wilding
No relevant relationships to disclose
G. Liu
No relevant relationships to disclose
W. R. Schelman
No relevant relationships to disclose